Molecular effects of short-term celecoxib treatment on head and neck squamous cell carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Head and neck cancer
- Focus Biomarker; Therapeutic Use
- 23 Dec 2015 Biomarkers information updated
- 19 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 19 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.